Location History:
- Palo Alto, CA (US) (2000 - 2003)
- Sunnyvale, CA (US) (2004)
- Menlo Park, CA (US) (2006 - 2019)
Company Filing History:
10 out of 10 
8 out of 142 
7 out of 302 
Years Active: 2000-2025
Title: **The Innovative Contributions of Bernd Jandeleit in Chemotherapeutic Agents**
Introduction
Bernd Jandeleit, based in Menlo Park, California, is recognized as a prolific inventor with a remarkable portfolio of 26 patents. His work primarily focuses on the development of chemotherapeutic agents, particularly in the realm of beta-substituted beta-amino acids and their analogs, showcasing significant potential in cancer treatment.
Latest Patents
Among Jandeleit’s latest patents are groundbreaking innovations involving beta-substituted beta-amino acids and their derivatives. These compounds are characterized as selective LAT1/4F2hc substrates, demonstrating swift uptake and retention in tumors that express the LAT1/4F2hc transporter. This unique ability positions these compounds as promising candidates for cancer therapies. Additionally, the patents include methods for synthesizing these beta-substituted beta-amino acid derivatives and analogs, along with their applications in treating various tumor types, displaying notable cytotoxicity.
Career Highlights
Throughout his career, Jandeleit has made significant strides in medicinal chemistry, contributing to advancements in cancer treatment. His endeavors have led to the creation of innovative compounds that target cancerous cells effectively, vastly improving therapeutic outcomes. He has worked with several organizations, including Quadriga Biosciences, Inc. and Xenoport, Inc., where he utilized his expertise to facilitate research and development in drug formulation.
Collaborations
In his professional journey, Jandeleit has collaborated with notable individuals such as Wolf-Nicolas Fischer and Kerry J Koller. These partnerships have undoubtedly enriched his research, allowing for a broader exploration of innovative approaches in the development of chemotherapeutic agents.
Conclusion
The contributions of Bernd Jandeleit are pivotal in the ongoing fight against cancer. His inventive spirit and commitment to advancing medicinal chemistry not only underscore his role as a leading inventor but also highlight the importance of innovation in the pharmaceutical industry. As the field continues to evolve, Jandeleit’s work stands as a testament to the potential that lies within targeted drug development.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.